Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases
Sector:
Health Technology
Industry:
Biotechnology
Employees:
39
Frequently Asked Questions
What is Market Cap of Argos Therapeutics, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Argos Therapeutics, Inc. market cap is $1.03M.
What is the 52-week high for Argos Therapeutics, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Argos Therapeutics, Inc. 52 week high is $5.80 as of October 28, 2025.
What is the 52-week low for Argos Therapeutics, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Argos Therapeutics, Inc. 52 week low is $0.0751 as of October 28, 2025.
What is Argos Therapeutics, Inc. stock price today?
Argos Therapeutics, Inc. stock price today is $0.0922.
What was Argos Therapeutics, Inc. stock price yesterday?
Argos Therapeutics, Inc. stock price yesterday was $0.0972.
What is the PE ratio of Argos Therapeutics, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Argos Therapeutics, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Argos Therapeutics, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Argos Therapeutics, Inc. P/B ratio is -0.1265.
What is Argos Therapeutics, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Argos Therapeutics, Inc.'s EBITDA is -0.44.
What is the 50-day moving average of Argos Therapeutics, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Argos Therapeutics, Inc. 50-day moving average is $0.1318.
How many employess does Argos Therapeutics, Inc. has?
